Delray Beach, FL, Oct. 08, 2026 (GLOBE NEWSWIRE) — MarketsandMarkets™ projects the global catheters market to grow from USD 30.53 billion in 2025 to USD 45.99 billion by 2030, registering a CAGR of 8.5% during the forecast period. Market growth is driven by the increasing global burden of chronic diseases, the growing geriatric population, rising demand for minimally invasive procedures, and continuous technological advancements in catheter design, materials, and surface coatings. The increasing adoption of catheter-based interventions across cardiovascular, urinary, and neurovascular applications is further supporting market expansion.
Get PDF Brochure – Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6247803
Key Market Highlights
- Market size, 2025: USD 30.53 billion
- Market forecast, 2030: USD 45.99 billion
- Growth rate: CAGR of 8.5% during 2025–2030
- Largest regional market: North America
- Largest type segment: Cardiovascular catheters
- Fastest-growing indication segment: Neurovascular conditions
- Key growth opportunities: Increasing demand in emerging markets, technological advancements, and expanding outpatient and home-based care
- Key players: Boston Scientific Corporation (US), Medtronic plc (Ireland), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), and Teleflex Incorporated (US)
Why This Market Matters
The growing prevalence of chronic diseases, including cardiovascular disorders, urinary tract infections, and neurovascular conditions, is increasing the demand for catheter-based diagnostic, surgical, and therapeutic interventions. The expanding geriatric population further contributes to market growth, as older adults frequently require catheterization for chronic disease management, surgical procedures, and long-term care. Healthcare providers are increasingly adopting minimally invasive and image-guided interventions that can improve procedural precision, reduce hospital stays, and support patient recovery.
Technological advancements, including antimicrobial coatings, hydrophilic surfaces, improved catheter steerability, and pressure-sensing smart catheters, are enhancing device performance and patient safety. Meanwhile, the shift toward outpatient and home-based care is expanding catheter use across ambulatory surgical centers, long-term care facilities, and outpatient clinics.
Market Overview
The catheters market is experiencing sustained growth as healthcare providers increasingly adopt advanced catheter technologies across diverse clinical applications. Rising investments in healthcare infrastructure, growing demand for minimally invasive procedures, and continuous product innovation are supporting adoption across hospitals, ambulatory surgical centers, diagnostic imaging centers, and long-term care facilities.
Manufacturers are strengthening their research and development capabilities to develop next-generation catheters with improved biocompatibility, enhanced navigation, greater infection resistance, and compatibility with imaging systems. Strategic acquisitions, product launches, and regional expansion are also enabling market participants to broaden their portfolios and address evolving clinical requirements.
However, product recalls, manufacturing quality issues, catheter-associated infections, and procedural complications remain important challenges. These factors are increasing the need for stringent quality assurance, advanced sterilization technologies, improved catheter designs, and effective infection prevention practices.
Analyst Perspective
The catheters market is evolving toward technologically advanced devices designed to improve procedural efficiency, patient safety, and clinical outcomes. Innovations in catheter materials, antimicrobial coatings, navigation systems, and imaging compatibility are supporting the adoption of catheter-based interventions across cardiovascular and neurovascular applications.
At the same time, the growing demand for healthcare services in emerging markets and the expansion of outpatient and home-based care are creating opportunities for manufacturers. Companies investing in product innovation, infection prevention, and specialized catheter solutions are expanding their offerings to meet the changing needs of healthcare providers and patients.
Speak to Our Analyst – Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=6247803
Segment Analysis
By type, the cardiovascular catheters segment accounted for the largest market share in 2024. Its leading position is attributed to the increasing prevalence of cardiovascular diseases, including coronary artery disease, heart failure, arrhythmias, and valvular heart disorders. These conditions frequently require minimally invasive catheter-based interventions such as angioplasty, cardiac ablation, and stenting. Advancements in catheter steerability, drug-eluting technologies, imaging compatibility, and biocompatibility are further supporting segment growth.
By indication, the neurovascular conditions segment is projected to witness the highest growth during the forecast period. The increasing incidence of strokes, brain aneurysms, arteriovenous malformations, and other cerebrovascular disorders is driving demand for catheter-based interventions. Advancements in microcatheters, guidewires, embolization coils, and neurothrombectomy devices are supporting the adoption of minimally invasive neurovascular procedures. The development of comprehensive stroke centers and increasing access to specialized neurointerventional care are also contributing to segment expansion.
Regional Analysis
North America dominated the catheters market in 2024, supported by its well-developed healthcare infrastructure, substantial healthcare expenditure, and early adoption of innovative medical devices. The high prevalence of chronic conditions, including cardiovascular disorders, diabetes, kidney diseases, and urinary tract infections, further contributes to catheter demand across hospitals, clinics, and ambulatory surgical centers.
The region also benefits from established distribution networks, supportive reimbursement policies, ongoing research and development activities, and the presence of major market participants. In addition, the aging population and increasing awareness of minimally invasive treatment options are supporting the adoption of advanced catheter technologies.
Emerging markets, including India, China, Brazil, and Southeast Asian countries, represent significant growth opportunities. Improving healthcare infrastructure, rising disposable incomes, increasing healthcare accessibility, and investments in medical device manufacturing are expected to support market expansion in these regions.
Key Industry Trends
- Increasing adoption of minimally invasive and catheter-based interventions.
- Growing demand for cardiovascular and neurovascular catheter technologies.
- Development of antimicrobial-coated catheters and advanced infection-prevention solutions.
- Increasing use of hydrophilic surfaces and improved catheter materials.
- Integration of navigation technologies and imaging system compatibility.
- Expansion of outpatient, ambulatory, and home-based healthcare services.
- Rising investments in research and development, product innovation, and manufacturing capacity.
- Strategic acquisitions and portfolio expansion by leading market participants.
Competitive Landscape
The catheters market is competitive, with the top five companies—Boston Scientific Corporation (US), Medtronic plc (Ireland), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), and Teleflex Incorporated (US)—holding a significant share of the global market.
Boston Scientific Corporation maintains a broad catheter portfolio spanning interventional cardiology, electrophysiology, and peripheral interventions. Its product development activities include advanced catheter technologies for minimally invasive procedures.
Medtronic plc offers catheter solutions across cardiovascular applications, including cardiac rhythm management, structural heart and aortic therapies, and coronary and peripheral vascular interventions. Its international operations and distribution network support its presence across global markets.
Becton Dickinson and Company strengthens its position through catheter technologies and connected-care solutions. Its acquisition of Edwards Lifesciences’ Critical Care product group in September 2024, valued at USD 4.2 billion, included advanced monitoring solutions and Swan-Ganz pulmonary artery catheters.
Johnson & Johnson Services, Inc., through its subsidiary Biosense Webster, participates in electrophysiology and ablation catheter systems, focusing on clinical precision and procedural efficiency. Teleflex Incorporated offers catheter products across vascular access, anesthesia, and urology applications.
Other prominent players include B. Braun SE, Stryker Corporation, Abbott Laboratories, Terumo Corporation, Coloplast A/S, Convatec Group PLC, Merit Medical Systems, Cook, Edwards Lifesciences Corporation, Nipro Corporation, Cardinal Health, Hollister Incorporated, Integra LifeSciences Corporation, Koninklijke Philips N.V., and MicroPort Scientific Corporation.
Market participants are focusing on technological innovation, product portfolio expansion, strategic acquisitions, and regional growth to address evolving clinical requirements and strengthen their market presence.
Related Reports
Cardiovascular Devices Market
Patient Monitoring Devices Market
CONTACT: About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook . Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: https://www.marketsandmarkets.com/